| Primary |
| Haemorrhage Prophylaxis |
27.8% |
| Crohn's Disease |
11.1% |
| Lung Infection |
11.1% |
| Helicobacter Test Positive |
8.3% |
| Asthma |
5.6% |
| Depression |
5.6% |
| Product Used For Unknown Indication |
5.6% |
| Angina Pectoris |
2.8% |
| Cystitis |
2.8% |
| Dyspepsia |
2.8% |
| Gastric Ph Decreased |
2.8% |
| Gastrooesophageal Reflux Disease |
2.8% |
| Gout |
2.8% |
| Haemostasis |
2.8% |
| Hepatic Cirrhosis |
2.8% |
| Vitamin Supplementation |
2.8% |
|
| Loss Of Consciousness |
16.7% |
| Cutaneous Lupus Erythematosus |
11.1% |
| Toxicity To Various Agents |
11.1% |
| Abdominal Pain |
5.6% |
| Bone Marrow Failure |
5.6% |
| Drug Ineffective |
5.6% |
| Duodenal Ulcer Haemorrhage |
5.6% |
| Hyponatraemia |
5.6% |
| Inappropriate Antidiuretic Hormone Secretion |
5.6% |
| Injection Site Erythema |
5.6% |
| Laceration |
5.6% |
| Pyrexia |
5.6% |
| Swelling Face |
5.6% |
| Vulvovaginal Candidiasis |
5.6% |
|
| Secondary |
| Product Used For Unknown Indication |
36.0% |
| Pain |
16.7% |
| Hypertension |
6.1% |
| Pyrexia |
5.7% |
| Gastrooesophageal Reflux Disease |
5.3% |
| Diarrhoea |
3.5% |
| Sleep Disorder |
3.5% |
| Renal Transplant |
2.6% |
| Drug Use For Unknown Indication |
2.2% |
| Anxiety Disorder |
1.8% |
| Arteriosclerosis Coronary Artery |
1.8% |
| Chronic Obstructive Pulmonary Disease |
1.8% |
| Hyperuricaemia |
1.8% |
| Lung Infection |
1.8% |
| Pharyngitis |
1.8% |
| Pneumonia |
1.8% |
| Respiratory Tract Infection |
1.8% |
| Thyroid Disorder |
1.8% |
| Depression |
1.3% |
| Diabetes Mellitus |
1.3% |
|
| Visual Impairment |
12.8% |
| Hyponatraemia |
10.6% |
| Inappropriate Antidiuretic Hormone Secretion |
8.5% |
| Constipation |
6.4% |
| Headache |
6.4% |
| Malaise |
6.4% |
| Pyrexia |
6.4% |
| Blood Creatine Phosphokinase Increased |
4.3% |
| Completed Suicide |
4.3% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
4.3% |
| Dyspnoea |
4.3% |
| Obstructive Airways Disorder |
4.3% |
| Rash |
4.3% |
| Stillbirth |
4.3% |
| Acute Hepatic Failure |
2.1% |
| Aggression |
2.1% |
| Anaemia |
2.1% |
| Anxiety |
2.1% |
| Asthma |
2.1% |
| Bone Marrow Failure |
2.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
43.3% |
| Pain |
6.8% |
| Prophylaxis |
6.3% |
| Hypertension |
5.8% |
| Rheumatoid Arthritis |
5.1% |
| Drug Use For Unknown Indication |
4.9% |
| Depression |
2.7% |
| Gastrooesophageal Reflux Disease |
2.7% |
| Diabetes Mellitus |
2.6% |
| Constipation |
2.5% |
| Infection |
2.4% |
| Premedication |
2.1% |
| Acute Leukaemia |
2.0% |
| Atrial Fibrillation |
1.8% |
| Thrombosis Prophylaxis |
1.7% |
| Anxiety |
1.6% |
| Chronic Lymphocytic Leukaemia |
1.5% |
| Multiple Myeloma |
1.5% |
| Nausea |
1.5% |
| Renal Transplant |
1.3% |
|
| Vomiting |
9.2% |
| Disseminated Intravascular Coagulation |
7.3% |
| Pyrexia |
7.3% |
| Death |
6.4% |
| Anaemia |
5.5% |
| Dyspnoea |
5.5% |
| Hypersensitivity |
5.5% |
| Drug Interaction |
4.6% |
| Headache |
4.6% |
| Malnutrition |
4.6% |
| Pneumonia |
4.6% |
| Renal Failure Acute |
4.6% |
| Supraventricular Extrasystoles |
4.6% |
| Clostridium Difficile Sepsis |
3.7% |
| Cough |
3.7% |
| Depression |
3.7% |
| Ivth Nerve Paresis |
3.7% |
| Sepsis |
3.7% |
| Somnolence |
3.7% |
| Tumour Haemorrhage |
3.7% |
|
| Interacting |
| Aspergillosis |
33.3% |
| Bacterial Infection |
16.7% |
| Immunosuppression |
16.7% |
| Encephalitis Viral |
8.3% |
| Neoplasm Prophylaxis |
8.3% |
| Peripheral T-cell Lymphoma Unspecified |
8.3% |
| Pyrexia |
8.3% |
|
| Arrhythmia Supraventricular |
66.7% |
| Immunosuppressant Drug Level Increased |
16.7% |
| Sepsis |
16.7% |
|
